Skip to content

史达手术

US · STAA #3168 按市值排名
21.27 -0.99 -4.45%
实时 - 追踪5344个代码 - 心跳于298秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量增加了2家。
  • 机构持股总比例下降了0.4个百分点。

机构持股

机构持股比例
110.86% -0.42pp
机构数量
243 +2
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Hedge Fund61.72%
Mutual Fund39.81%
Public Company6.93%
Individual/Insider0.89%
Government Pension Fund0.82%
Sovereign Wealth Fund0.73%
Private Company0.45%
Insurance Company0.29%

主要股东 截至 2026-06-30

Broadwood Capital, Inc. 32.16% · 16.12M 股
BlackRock 13.42% · 6.73M 股
Madison Avenue Partners, LP 8.33% · 4.18M 股
Yunqi Capital Limited 6.50% · 3.26M 股
Point72 Asset Management, L.P. 4.86% · 2.44M 股
The Goldman Sachs Group, Inc. 4.07% · 2.04M 股
Vanguard Portfolio Management, LLC 3.95% · 1.98M 股
Vanguard Capital Management, LLC 3.74% · 1.87M 股
State Street Global Advisors 3.53% · 1.77M 股
Anatole Investment Management Limited 3.29% · 1.65M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 38次买入 · 11次卖出

姓名职务持股比例
Broadwood Capital, Inc. -- 32.16%
Warren Foust Chief Operating Officer 0.19%
Stephen Farrell Lead Independent Director 0.16%
Wei Jiang Independent Director 0.15%
Magda Michna Chief Clinical, Regulatory & Medical Affairs Officer 0.08%
Deborah Andrews Former Chief Financial Officer 0.08%
Nathaniel Sisitsky General Counsel 0.06%
Neal Bradsher Director 0.05%
Richard LeBuhn Director 0.04%
Louis Silverman Former Independent Chairperson 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-08-13 Deborah Andrews Former Chief Financial Officer Derivative Exercise and Sale -2,662 $26.18
2026-08-13 Deborah Andrews Former Chief Financial Officer Other Derivative Acquisition +4,975 --
2026-08-13 Deborah Andrews Former Chief Financial Officer Other Derivative Acquisition +8,952 $26.18
2026-08-13 Deborah Andrews Former Chief Financial Officer Other Derivative Acquisition +29,159 $26.18
2026-08-13 Deborah Andrews Former Chief Financial Officer Derivative Exercise and Retained +2,571 --
2026-08-13 Magda Michna Chief Clinical, Regulatory & Medical Affairs Officer Derivative Exercise and Sale -3,356 $26.18
2026-08-13 Magda Michna Chief Clinical, Regulatory & Medical Affairs Officer Derivative Exercise and Retained +3,243 $26.18
2026-08-13 Warren Foust Chief Operating Officer Derivative Exercise and Sale -5,595 $26.18
2026-08-13 Warren Foust Chief Operating Officer Other Derivative Acquisition +22,493 --
2026-08-13 Warren Foust Chief Operating Officer Other Derivative Acquisition +78,433 $26.18
2026-08-13 Warren Foust Chief Operating Officer Other Derivative Acquisition +255,489 $26.18
2026-08-13 Warren Foust Chief Operating Officer Derivative Exercise and Retained +5,402 --
2026-07-30 Deborah Andrews Former Chief Financial Officer Derivative Exercise and Sale -17,056 $24.36–31.21
2026-07-30 Deborah Andrews Former Chief Financial Officer Derivative Exercise and Retained +17,686 --
2026-07-30 Warren Foust Chief Operating Officer Derivative Exercise and Sale -10,576 $24.36
2026-07-30 Warren Foust Chief Operating Officer Derivative Exercise and Retained +10,211 --
2026-06-17 Louis Silverman Former Independent Chairperson Other Derivative Acquisition +6,182 --
2026-06-17 Louis Silverman Former Independent Chairperson Derivative Exercise and Retained +10,683 --
2026-06-17 Neal Bradsher Director Other Derivative Acquisition +11,145 $29.12
2026-06-17 Lilian Zhou Director Other Derivative Acquisition +3,091 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

史达手术 讨论区 0 条评论

发表评论